Mexican entrepreneur wins contest with a solution to blindness – El Sol de México

Arián Marín Tapia, a Mexican entrepreneur and career biologist, turned out to be the winner of the contest An idea to change history 2021 in its seventh edition, organized by the television channel television restricted History. Won with prototype 3D bioprinting corneas with personalized stem cells to restore sight.

The award ceremony was held in a hotel in this capital, hosted by César Sabroso Senior VIP of A&E Networks Marketingin the company of the executive Michel Lassauzet, Deputy Director of Communications of Nissan Mexico Marketing on its 60th anniversary, who presented the trophy and the economic remuneration of 250 thousand pesos to Arián Marín.

Within five to seven years, the winner will perfect the master prototype of BioTinta, which is a stem cell gel, which will lead the patient to regain their sight.

In interview with The Sun of MexicoArián Marín Tapia, who attended the award ceremony with his partner daniel moonexpressed that worldwide there are 10 million people waiting for a corneal transplant, and of these in Mexico, “we are talking about an estimated between 5,500 and 6,000 patients waiting for a cornea donation, who have between 20 and 60 years of age”, he indicated.

Marín Tapia announced that with the 250,000 pesos from the prize, “we will buy equipment and supplies to start up our research laboratory in the Faculty of Sciences of the Autonomous Mexico State UniversityWe have an agreement with her”.

➡️ Subscribe to our Newsletter and receive the most relevant notes in your email

He explained that he still cannot register his invention, “because it is part of my doctorate and it is being formulated.”

Arián regrets that in Mexico, “the population suffers from lack of sight because their corneas have deteriorated and treatments are limited and expensive; blindness is irreversible, the last thing that remains is the transplant that not everyone can access, bringing a cornea from the United States costs three thousand dollars. We put our project within the reach of these patients and we will also make a program for low-income patients”.


Available on: Acast, Spotify, Apple Podcasts, Google Podcasts, Deezer and Amazon Music